Expressions and Significance of ALDH1,HIF-1α and VEGF in Laryngeal Squamous Cell Carcinoma

ZHAO Yan, JIN Xin, LI Nan. et al

Abstract

To investigate the expressions of aldehyde dehydrogenase 1(ALDH1), hypoxia-inducible factor 1α(HIF-1α), vascular endothelial growth factor (VEGF) in laryngeal squamous cell carcinoma(LSCC) and their relationships with clinical significance. Methods In situ hybridization (ISH) method and immuohistochemical staining were used to detect the mRNA and protein expressions of ALDH1,HIF-1α and VEGF in 120 LSCC specimens and 60 cases of normal laryngeal tissue.Their relationships with clinical pathological parameters were analyzed. Results The positive rates of ALDH1,HIF-1α and VEGF mRNA in LSCC were 57.5%(69/120), 73.3%(88/120), 56.7% (68/120), while the positive rates of proteins were 55.8%(67/120),70.8%(85/120) and 55.0% (66/120), respectively. which were significantly higher than those in controls(P<0.05). The expression of ALDH1 and VEGF proteins were significantly correlated with TNM stage and lymph node metastasis (P<0.05). The expression of HIF-1α protein was significantly correlated with TNM stage, the degree of differentiation and lymph node metastasis (P<0.05). The positive expression of ALDH1 was positively associated with those of HIF-1α and VEGF (P<0.05). The lymph node metastasis rate increased with the positive factors. Kaplan-Meier survival analysis showed that the patients with positive expression of ALDH1,HIF-1α and VEGF had lower 5-year overall survival rate than those with negative expression (P<0.05). Conclusion The expressions of ALDH1,HIF-1α and VEGF are higher in LSCC,which may be used to determine the malignancy and prognosis of LSCC .

 

Keywords: Laryngeal squamous cell carcinoma, Aldehyde dehydrogenase 1, Hypoxia -inducible factor 1α, Vascular endothelial growth factor, Immuohistochemistry 

 

Full Text:

PDF


References


LEE YH, BAE HC, NOH KH. Et al. Gain of HIF-la under normoxia in cancer mediates immune adaptation through the AKT/ERK and VEGFA axes. Clin Cancer Res,2015,21(6); 1438-1446.

JIANG F. QIU Q, KHANNA A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell associated marker in lung cancer. Mol Cancer Res,2009,7(3);330-338.

GARNER P'F, BEIERLE EA. Cancer stem cells and their interaction with the tumor microenvironment in neuroblastoma. Cancers (Basel), 2015, 8(1). pii; E5. doi; 10. 3390/cancers8010005.

DE ВЕСА FF, CAETANO P, GERHARD R, etal. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. J Clin Pathol. 2013, 66 ( 3 ); 187- 191.

GINESTIER C, HUR МН. CHARAFE-JAUFFRET E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell.2007,1(5):555-567.

KISEK. КINUG ASA- К AT A Y AM A Y, TAKAKURA N. Tumor microenvironment for cancer stem cells. Adv Drug Deliv Rev,2015,9(8): 195-197.

MYSZCZYSZYN A, CZARNECKA AM. MATAK D, et al. The role of hypoxia and cancer stem cells in renal cell carcinoma pathogenesis. Stem Cell Rev, 2015, 11 (6); 919- 943.

NGUYEN LK. CAVADAS MA, SCHOLZ CC, et al. A dynamic model of the hypoxia-inducible factor la (HIF-la) network. J Cell Sci,2013.126СPt 6): 1454-1463.

METHENI M, LOMBESA, BOUILLAUD ¥,et al. HIF-la induction, proliferation and glycolysis of Theileria-infected leukocytes. Cell Microbiol.2015,17(4):467-472.

ROMAIN B, HACHET-HAAS M, ROHR S4, et al. Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer. Mol Cancer, 2014, 13: 58 [ 2016-04-30 ]. https:// www. ncbi. nlm. nih. gov/pmc/articles/PMC3975457/. doi: 10. 1186/1476-4598-13-58.

MARONI P, MATTEUCCI E, DRAGO L, et al. Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-la stabilization/nuclear translocation in bone metastasis from breast carcinoma. Exp Cell Res, 2015, 330 (2):287-299.

KONDO K, KANEKO T, BABA M, et al. VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. Biol Pharm Bull,2007 ,30(4) ;633-637.

FRAGACA, DE OLIVEIRA MV, DE OLIVEIRA ЁS. A high HIF-la expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients. Oral Oncol,2012,48(2): 130-135.


Refbacks

  • There are currently no refbacks.